Treatment of Dupuytren's Contracture at the Present Stage (Literature Review)
https://doi.org/10.29413/ABS.2019-4.6.11
Abstract
Dupuytren disease is widespread among the population of different countries (3 %) and affects the working-age male population to a greater extent.
The progressive nature of the course of Dupuytren disease causes a persistent and significant decrease in the functional capabilities of the hands of patients and leads to a limitation of fine and high-precision activity on average in 67 % of patients, and in 3 % causes disability.
The problem of treating patients with Dupuytren's contracture remains relevant despite the achievements ofhand surgery. A large number of applied methods speaks of both the urgency of the problem and the possibility of a comprehensive approach to treating patients with this disease at different stages and with varying degrees of severity of contracture of the fingers. Many techniques for treating Dupuytren's contracture and their modifications are described. These are extensive surgical interventions, which involve the complete excision of the palmar aponeurosis, and selective open interventions, which involve the removal of only macro-modified areas - the bundle of the palmar aponeurosis through one large or several small accesses. With the development of minimally invasive techniques, needle-based aponeurotomy methods have spread, which do not imply the removal of pathologically altered tissues, but only relieve tension in the tissue by dissecting it and thereby increase movements in the joints of the fingers. With the development of pharmacology, methods for the enzymatic destruction of the bundle of pathologically altered palmar aponeurosis have appeared.
The evolution of approaches to the treatment of Dupuytren's contracture is visible in a gradual transitionfrom complete excision of the palmar aponeurosis to selective techniques, and from them to partial dissections and further to needle and enzymatic methods. However, despite the abundance of methods and good results in treating patients with this pathology, there remains a percentage of relapses, complications and adverse outcomes, the reduction of which is the purpose of developing a modern understanding of this pathology.
About the Authors
Ch. Z. ButaevRussian Federation
Chingiz Z. Butaev - Junior Research Officer at the Scientific Clinical Department of Traumatology.
Bortsov Revolyutsii str. 1, Irkutsk 664003
I. A. Kuklin
Russian Federation
Igor A. Kuklin - Dr. Sc. (Med.), Leading Research Officer at the Scientific Clinical Department of Traumatology.
Bortsov Revolyutsii str. 1, Irkutsk 664003
References
1. Ling RS. The genetic factor in dupuytren's disease. J Bone Joint Surg Br. 1963; 45B(4): 709-718.
2. Topalov PD. To etiology, pathogenesis and clinic of Dupuytren's contracture. Ortopediya i travmatologiya. 1963; 12: 3641. (In Russ.)
3. Berger A, Delbruck A, Brenner P, Hinzmann R. Dupuytren's disease: pathobiochemistry and clinical management. Berlin, Heidelberg: Springer-Verlag; 1994.
4. Gubochkin NG, Shapovalov VM. Selected Issues of Hand Surgery. Saint-Petersburg, 2008. (In Russ.)
5. Mikusev IE. Dupuytren's contracture and profession. Orto-pediya i travmatologiya. 1985; 7: 42-43. (In Russ.)
6. Shinkarenko IN. Diagnosis and treatment of the initial stages of Dupuytren's contracture. Zdravookhranenie Belorussii. 1972; 1: 72-75. (In Russ.)
7. Bogov AA, Mullin RI, Filipov VL, Topyrkin VG. The results of the use of needle aponeurotomy in combination with lipofilling in the treatment of Dupuytren's contracture. Prakticheskaya med-itsina. 2016; 4(96): 59-62. (In Russ.)
8. Volkova AM, Kuznetsova HL. Dupuytren's contracture (Classification, clinic, diagnosis, treatment, medical examination): guidelines. Sverdlovsk, 1986. (In Russ.)
9. Volkova AM. Hand Surgery. Vol. 2. Sverdlovsk, 1993; 10-58. (In Russ.)
10. Vorobev VN. Dupuytren's contracture and its surgical treatment. Vestnik khirurgii. 1957; 12: 41-46. (In Russ.)
11. Goridova LD. Dupuytren's disease, surgical treatment and some issues of etiopathogenesis: Abstract of Dissertation Thesis of Candidate of Medical Sciences. Kharkiv, 1979. (In Russ.)
12. Tubiana R, Simmons BP, DeFrenne HA. Location of Dupuytren's disease on the radial aspect of the hand. Clin. Orthop. Relat. Res. 1982; 168: 222-229.].
13. Rodrigo JJ, Niebauer JJ, Brown RL, Doyle JR. Treatment of Dupuytren's contracture. Long-term results after fasciotomy and fascial excision. J Bone Joint Surg Am. 1976; 58(3): 380-387.
14. Aykut S, Baydar M, Buyuk AF, Ozturk iA, Ozden E, Ozturk K. Surgical treatment results for Dupuytren's disease. Acta Ortop Bras. 2017; 25(3): 71-73. doi: 1 0.1590/1413-785220172503164827.
15. Moermans JP. Segmental aponeurectomy in Dupuytren's disease. J Hand Surg Br. 1991; 16(3): 243-254.
16. Tonkin MA, Burke FD, Varian JP. Dupuytren's contracture: a comparative study of fasciectomy and dermofasciectomy in one hundred patients. J Hand Surg Br. 1984; 9(2): 156-162.
17. Hueston JT. Digital Wolfe grafts in recurrent Dupuytren's contracture. Plast Reconstr Surg Transplant Bull. 1962; 29: 342-344.
18. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003; 28(5): 427-443.
19. Trojian TH, Chu SM. Dupuytren's disease: diagnosis and treatments. Am Family Physician. 2007: 76(1): 86-89.
20. Novikov AV, Petrov SV. Treatment of patients with Dupuytren's contracture: clinical recommendations. Nizhny Novgorod, 2013. (In Russ.)
21. Hovius SE, Kan HJ, Smit X, et al. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg. 2011; 128(1): 221-228. doi: 10.1097/PRS.0b013e31821741ba.
Review
For citations:
Butaev Ch.Z., Kuklin I.A. Treatment of Dupuytren's Contracture at the Present Stage (Literature Review). Acta Biomedica Scientifica. 2019;4(6):72-76. (In Russ.) https://doi.org/10.29413/ABS.2019-4.6.11